Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D31ORV
|
|||
| Drug Name |
ADP-A2AFP
|
|||
| Drug Type |
CAR-T cell therapy
|
|||
| Indication | Liver cancer [ICD-11: 2C12; ICD-10: C22] | Phase 1 | [1] | |
| Company |
Adaptimmune
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03132792) A Phase I Open Label Clinical Trial Evaluating the Safety and Anti-Tumor Activity of Autologous T Cells Expressing Enhanced TCRs Specific for Alpha Fetoprotein (AFP????T) in HLA-A2 Positive Subjects With Advanced Hepatocellular Carcinoma (HCC) or Other AFP Expressing Tumor Types. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.